The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells. (Q40571024)
scientific article published on April 2004
Language:
(P31) (Q13442814)
(P50) (Q43937223)
(Q1532952)
(Q125291234)
(P304) 2343-2346
(P407) (Q1860)
(P433) 7
(P478) 64
(P577) Thursday, April 1, 2004
(P921) (Q79460)
(Q412616)
(P1433) (Q326097)
(P1476) "The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells" (language: en)
other details
description scientific article published on April 2004

External Links